Form 4: Bio-Rad Laboratories CFO Robin Harper Cowie Reports Stock Sales to Cover Taxes on RSU Vesting

Robin Harper Cowie, CFO, Secretary, and Treasurer of Biodesix Inc., reports the sale of common stock to cover taxes upon the vesting of Restricted Stock Units (RSUs).

Summary

• Robin Harper Cowie, the CFO, Secretary, and Treasurer of BIODESIX INC [BDSX], filed a Form 4 detailing changes in beneficial ownership.
• The report covers transactions from August 8, 2024, to August 12, 2024.
• Cowie sold shares of common stock to cover taxes upon the vesting of Restricted Stock Units (RSUs).
• On August 8, 2024, 3,157 shares were acquired through the vesting of RSUs.
• On August 9, 2024, 724 shares were sold at a price of $1.601.
• On August 12, 2024, 251 shares were sold at a price of $1.5719.
• Following these transactions, Cowie beneficially owns 191,151 shares of Biodesix Inc.
• The RSUs vest in sixteen successive quarterly installments from February 8, 2022.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing relates to routine stock sales for tax purposes, which doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and potential future performance.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders due to the slight dilution of shares, but it is primarily a result of tax obligations from RSU vesting.

Key Dates